On our radar in this week's brief exploration of recently published HIV-related research:
- A suppressed plasma viral load may not mean a suppressed viral load in rectal mucosa.
- Engagement in care is less than stellar among people on pre-exposure prophylaxis (PrEP).
- We should probably be paying much better attention to depression and mental health among women with HIV.
- Dolutegravir monotherapy might be a little more than the drug's high resistance barrier can bear.
Read on for further details on each of these data-backed assertions. To beat HIV, you have to follow the science!
Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.
Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.